9,867 Shares in Hawkins, Inc. $HWKN Acquired by The Manufacturers Life Insurance Company

The Manufacturers Life Insurance Company purchased a new stake in shares of Hawkins, Inc. (NASDAQ:HWKN) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 9,867 shares of the specialty chemicals company’s stock, valued at approximately $1,402,000.

Several other large investors also recently made changes to their positions in the business. Values First Advisors Inc. increased its stake in shares of Hawkins by 0.8% in the first quarter. Values First Advisors Inc. now owns 9,855 shares of the specialty chemicals company’s stock valued at $1,514,000 after buying an additional 79 shares in the last quarter. Truist Financial Corp grew its holdings in Hawkins by 4.7% during the 4th quarter. Truist Financial Corp now owns 1,852 shares of the specialty chemicals company’s stock worth $263,000 after acquiring an additional 83 shares during the last quarter. ProShare Advisors LLC increased its position in Hawkins by 3.0% in the 4th quarter. ProShare Advisors LLC now owns 3,815 shares of the specialty chemicals company’s stock valued at $542,000 after acquiring an additional 112 shares in the last quarter. Quantinno Capital Management LP increased its position in Hawkins by 0.9% in the 2nd quarter. Quantinno Capital Management LP now owns 13,618 shares of the specialty chemicals company’s stock valued at $1,935,000 after acquiring an additional 124 shares in the last quarter. Finally, Sanctuary Advisors LLC raised its stake in shares of Hawkins by 6.1% in the first quarter. Sanctuary Advisors LLC now owns 2,371 shares of the specialty chemicals company’s stock worth $364,000 after acquiring an additional 137 shares during the last quarter. Institutional investors own 69.71% of the company’s stock.

Hawkins Trading Up 2.3%

Shares of NASDAQ HWKN opened at $129.33 on Friday. Hawkins, Inc. has a fifty-two week low of $116.04 and a fifty-two week high of $186.15. The firm has a market capitalization of $2.70 billion, a P/E ratio of 33.51, a P/E/G ratio of 2.57 and a beta of 0.77. The company has a debt-to-equity ratio of 0.45, a current ratio of 2.27 and a quick ratio of 1.54. The company’s 50 day simple moving average is $132.97 and its 200 day simple moving average is $146.65.

Hawkins (NASDAQ:HWKN) last posted its quarterly earnings results on Wednesday, July 29th. The specialty chemicals company reported $1.35 earnings per share for the quarter, missing analysts’ consensus estimates of $1.39 by ($0.04). Hawkins had a net margin of 7.29% and a return on equity of 15.42%. The company had revenue of $315.68 million during the quarter, compared to analyst estimates of $313.42 million. On average, analysts predict that Hawkins, Inc. will post 4.1 EPS for the current year.

Hawkins Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, August 28th. Shareholders of record on Friday, August 14th were issued a $0.19 dividend. The ex-dividend date was Friday, August 14th. This represents a $0.76 annualized dividend and a yield of 0.6%. Hawkins’s dividend payout ratio (DPR) is 20.73%.

Insider Buying and Selling at Hawkins

In other news, VP Douglas Lange acquired 910 shares of the stock in a transaction that occurred on Tuesday, August 25th. The stock was acquired at an average price of $118.75 per share, for a total transaction of $108,062.50. Following the transaction, the vice president directly owned 28,169 shares in the company, valued at approximately $3,345,068.75. This represents a 3.34% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at this link. Also, CFO Jeffrey P. Oldenkamp bought 1,290 shares of Hawkins stock in a transaction on Thursday, August 27th. The shares were acquired at an average price of $119.00 per share, for a total transaction of $153,510.00. Following the completion of the acquisition, the chief financial officer owned 104,223 shares of the company’s stock, valued at approximately $12,402,537. This represents a 1.25% increase in their position. The disclosure for this purchase is available in the SEC filing. Company insiders own 3.70% of the company’s stock.

Analyst Ratings Changes

HWKN has been the topic of several research analyst reports. BWS Financial reissued a “buy” rating and set a $200.00 price target on shares of Hawkins in a research note on Monday, August 3rd. Weiss Ratings lowered Hawkins from a “hold (c+)” rating to a “hold (c)” rating in a research report on Thursday, August 27th. Barclays set a $142.00 target price on Hawkins and gave the stock an “equal weight” rating in a research report on Friday, July 31st. Finally, Zacks Research lowered Hawkins from a “hold” rating to a “strong sell” rating in a research note on Tuesday, August 4th. One equities research analyst has rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, Hawkins currently has a consensus rating of “Hold” and an average target price of $171.00.

Hawkins Profile

Hawkins, Inc (NASDAQ: HWKN) is a specialty chemical company that produces and distributes water-treatment and industrial chemicals across North America. Founded in 1938 and headquartered in Roseville, Minnesota, the company has built a network of manufacturing facilities and distribution centers that serve municipal, industrial and commercial customers. As a publicly traded entity, Hawkins leverages its long-standing presence in the chemical distribution industry to provide tailored solutions for complex water-treatment challenges and specialty chemical needs.

Hawkins’ product portfolio encompasses a wide range of chemicals, including sodium hypochlorite, sodium hydroxide, hydrogen peroxide, chlorine, acids and specialty blends.